Persistent pubertal macromastia

S. P. Marynick, B. C. Nisula, J. C. Pita, Donald (Lynn) Loriaux

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Pubertal gynecomastia is a transient phenomenon of several months duration, whereas pubertal macromastia, which can be defined as the development of female-appearing breasts in otherwise normal males at puberty, persists into adulthood. The possibility that abnormalities of sex steroid levels or sex steroid-binding globulin (TeBG) might be involved in the persistence of pubertal macromastia led us to compare the endocrine profiles of nine men with this disorder with those of nine age-matched controls. The patients ranged in age from 15-31 yr, with macromastia being present for 8.7±2.0 yr (mean±SE). Comparison of the macromastia patients with the controls revealed no differences in plasma testosterone (546±77 vs. 539±86 ng/100 ml), estradiol (44±77 vs. 47±8 pg/ml), TeBG-binding capacity (0.83±0.07 vs. 0.89±0.12 μg/100ml), TeBG-binding affinity (1.92±0.14 vs. 1.77±0.18 liters/nM), and PRL concentration (11.4±1.8 vs. 12.4±2.7 ng/ml). Also, no differences were found in plasma LH or FSH levels in samples collected every 20 min over an 8-h period (LH, 9.0±0.9 vs. 8.1±1.2 mIU/ml; FSH, 7.2±1.0 vs. 6.1±1/1 mIU/ml). The number of LH and FSH secretory spikes occurring during 8 h were not different in the two groups (LH, 2.7±0.5 vs. 2.9±0.3; FSH, 2.0±0.6 vs. 1.6±0.5). LH and FSH increases after 100 μg LRH were similar (LH, 38.3±4.5 vs. 31.2±5.8 mIU/ml; FSH, 7.7±2.4 vs. 5.1±0.7 mIU/ml). The breast tissue histology showed ductular development, fat cells, and fibrous tissue typical of chronic gynecomastia of other causes. We conclude that the persistence of pubertal macromastia is not associated with demonstrable abnormalities in gonadotropins, PRL, plasma sex steroids, or plasma TeBG.

Original languageEnglish (US)
Pages (from-to)128-130
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume50
Issue number1
StatePublished - 1980
Externally publishedYes

Fingerprint

Plasmas
Steroids
Gynecomastia
Tissue
Breast
Histology
Globulins
Gonadotropins
Testosterone
Estradiol
Puberty
Adipocytes
Fats
Gigantomastia

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Marynick, S. P., Nisula, B. C., Pita, J. C., & Loriaux, D. L. (1980). Persistent pubertal macromastia. Journal of Clinical Endocrinology and Metabolism, 50(1), 128-130.

Persistent pubertal macromastia. / Marynick, S. P.; Nisula, B. C.; Pita, J. C.; Loriaux, Donald (Lynn).

In: Journal of Clinical Endocrinology and Metabolism, Vol. 50, No. 1, 1980, p. 128-130.

Research output: Contribution to journalArticle

Marynick, SP, Nisula, BC, Pita, JC & Loriaux, DL 1980, 'Persistent pubertal macromastia', Journal of Clinical Endocrinology and Metabolism, vol. 50, no. 1, pp. 128-130.
Marynick, S. P. ; Nisula, B. C. ; Pita, J. C. ; Loriaux, Donald (Lynn). / Persistent pubertal macromastia. In: Journal of Clinical Endocrinology and Metabolism. 1980 ; Vol. 50, No. 1. pp. 128-130.
@article{3eec1e9b1fb6499b89fedf0412ab8b24,
title = "Persistent pubertal macromastia",
abstract = "Pubertal gynecomastia is a transient phenomenon of several months duration, whereas pubertal macromastia, which can be defined as the development of female-appearing breasts in otherwise normal males at puberty, persists into adulthood. The possibility that abnormalities of sex steroid levels or sex steroid-binding globulin (TeBG) might be involved in the persistence of pubertal macromastia led us to compare the endocrine profiles of nine men with this disorder with those of nine age-matched controls. The patients ranged in age from 15-31 yr, with macromastia being present for 8.7±2.0 yr (mean±SE). Comparison of the macromastia patients with the controls revealed no differences in plasma testosterone (546±77 vs. 539±86 ng/100 ml), estradiol (44±77 vs. 47±8 pg/ml), TeBG-binding capacity (0.83±0.07 vs. 0.89±0.12 μg/100ml), TeBG-binding affinity (1.92±0.14 vs. 1.77±0.18 liters/nM), and PRL concentration (11.4±1.8 vs. 12.4±2.7 ng/ml). Also, no differences were found in plasma LH or FSH levels in samples collected every 20 min over an 8-h period (LH, 9.0±0.9 vs. 8.1±1.2 mIU/ml; FSH, 7.2±1.0 vs. 6.1±1/1 mIU/ml). The number of LH and FSH secretory spikes occurring during 8 h were not different in the two groups (LH, 2.7±0.5 vs. 2.9±0.3; FSH, 2.0±0.6 vs. 1.6±0.5). LH and FSH increases after 100 μg LRH were similar (LH, 38.3±4.5 vs. 31.2±5.8 mIU/ml; FSH, 7.7±2.4 vs. 5.1±0.7 mIU/ml). The breast tissue histology showed ductular development, fat cells, and fibrous tissue typical of chronic gynecomastia of other causes. We conclude that the persistence of pubertal macromastia is not associated with demonstrable abnormalities in gonadotropins, PRL, plasma sex steroids, or plasma TeBG.",
author = "Marynick, {S. P.} and Nisula, {B. C.} and Pita, {J. C.} and Loriaux, {Donald (Lynn)}",
year = "1980",
language = "English (US)",
volume = "50",
pages = "128--130",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Persistent pubertal macromastia

AU - Marynick, S. P.

AU - Nisula, B. C.

AU - Pita, J. C.

AU - Loriaux, Donald (Lynn)

PY - 1980

Y1 - 1980

N2 - Pubertal gynecomastia is a transient phenomenon of several months duration, whereas pubertal macromastia, which can be defined as the development of female-appearing breasts in otherwise normal males at puberty, persists into adulthood. The possibility that abnormalities of sex steroid levels or sex steroid-binding globulin (TeBG) might be involved in the persistence of pubertal macromastia led us to compare the endocrine profiles of nine men with this disorder with those of nine age-matched controls. The patients ranged in age from 15-31 yr, with macromastia being present for 8.7±2.0 yr (mean±SE). Comparison of the macromastia patients with the controls revealed no differences in plasma testosterone (546±77 vs. 539±86 ng/100 ml), estradiol (44±77 vs. 47±8 pg/ml), TeBG-binding capacity (0.83±0.07 vs. 0.89±0.12 μg/100ml), TeBG-binding affinity (1.92±0.14 vs. 1.77±0.18 liters/nM), and PRL concentration (11.4±1.8 vs. 12.4±2.7 ng/ml). Also, no differences were found in plasma LH or FSH levels in samples collected every 20 min over an 8-h period (LH, 9.0±0.9 vs. 8.1±1.2 mIU/ml; FSH, 7.2±1.0 vs. 6.1±1/1 mIU/ml). The number of LH and FSH secretory spikes occurring during 8 h were not different in the two groups (LH, 2.7±0.5 vs. 2.9±0.3; FSH, 2.0±0.6 vs. 1.6±0.5). LH and FSH increases after 100 μg LRH were similar (LH, 38.3±4.5 vs. 31.2±5.8 mIU/ml; FSH, 7.7±2.4 vs. 5.1±0.7 mIU/ml). The breast tissue histology showed ductular development, fat cells, and fibrous tissue typical of chronic gynecomastia of other causes. We conclude that the persistence of pubertal macromastia is not associated with demonstrable abnormalities in gonadotropins, PRL, plasma sex steroids, or plasma TeBG.

AB - Pubertal gynecomastia is a transient phenomenon of several months duration, whereas pubertal macromastia, which can be defined as the development of female-appearing breasts in otherwise normal males at puberty, persists into adulthood. The possibility that abnormalities of sex steroid levels or sex steroid-binding globulin (TeBG) might be involved in the persistence of pubertal macromastia led us to compare the endocrine profiles of nine men with this disorder with those of nine age-matched controls. The patients ranged in age from 15-31 yr, with macromastia being present for 8.7±2.0 yr (mean±SE). Comparison of the macromastia patients with the controls revealed no differences in plasma testosterone (546±77 vs. 539±86 ng/100 ml), estradiol (44±77 vs. 47±8 pg/ml), TeBG-binding capacity (0.83±0.07 vs. 0.89±0.12 μg/100ml), TeBG-binding affinity (1.92±0.14 vs. 1.77±0.18 liters/nM), and PRL concentration (11.4±1.8 vs. 12.4±2.7 ng/ml). Also, no differences were found in plasma LH or FSH levels in samples collected every 20 min over an 8-h period (LH, 9.0±0.9 vs. 8.1±1.2 mIU/ml; FSH, 7.2±1.0 vs. 6.1±1/1 mIU/ml). The number of LH and FSH secretory spikes occurring during 8 h were not different in the two groups (LH, 2.7±0.5 vs. 2.9±0.3; FSH, 2.0±0.6 vs. 1.6±0.5). LH and FSH increases after 100 μg LRH were similar (LH, 38.3±4.5 vs. 31.2±5.8 mIU/ml; FSH, 7.7±2.4 vs. 5.1±0.7 mIU/ml). The breast tissue histology showed ductular development, fat cells, and fibrous tissue typical of chronic gynecomastia of other causes. We conclude that the persistence of pubertal macromastia is not associated with demonstrable abnormalities in gonadotropins, PRL, plasma sex steroids, or plasma TeBG.

UR - http://www.scopus.com/inward/record.url?scp=0018864293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018864293&partnerID=8YFLogxK

M3 - Article

C2 - 7188613

AN - SCOPUS:0018864293

VL - 50

SP - 128

EP - 130

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -